Results 181 to 190 of about 2,567,418 (399)

Our duty [PDF]

British Dental Journal, 2011
openaire   +2 more sources

Investigating the impacts of charge composition and temperature on ammonia/hydrogen combustion in a heavy-duty spark-ignition engine

Zining Yu, Rui Yang, Zongyu Yue, Mingfa Yao   +3 more
openalex   +1 more source

Calculation of the Duty Cycle for BECA

, 2015
Chiranjib Patra, Sourish Mullick
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Nanobiotechnology-driven advances in sonodynamic therapy: unlocking the potential of sonosensitizers in clinical translation. [PDF]

RSC Adv
Zeng Z, Tian T, Liu J, Bai L, Zhang J, Nie C, Liu B, Chen C, Lu W.   +8 more
europepmc   +1 more source

“I was told that my first duty was to forget physiology, which had no relation to medicine” [PDF]

, 2016
Kieran Walsh
openalex   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Evaluation of the administrative chief duty system in a tertiary reproductive hospital through personnel analysis. [PDF]

Sci Rep
Liang FF, Zeng ZY, Zhou WW, Li L, Shah S, Liang L, Que T, Mehmood A, Lin Z, Mo Y.   +9 more
europepmc   +1 more source

"THE ROYAL COLLEGE OF SURGEONS OF ENGLAND AND THE CORPORATION DUTY."

, 1898
W.G. Dickinson
openalex   +2 more sources

Education Outcomes in a Duty‐Hour Flexibility Trial in Internal Medicine

New England Journal of Medicine, 2018
S. Desai, D. Asch, L. Bellini, K. Chaiyachati, Manqing Liu, A. Sternberg, J. Tonascia, Alyssa Yeager, Jeremy M. Asch, J. Katz, M. Basner, D. Bates, K. Bilimoria, D. Dinges, O. Even-Shoshan, David M. Shade, J. Silber, Dylan S. Small, K. Volpp, J. Shea   +19 more
semanticscholar   +1 more source